Target intelligence / Profile preview

Double-stranded DNA minor groove at AT-rich sequences (DNA minor groove (AT-rich))

Target
DNA minor groove (AT-rich)
Molecular classification
Nucleic acid, DNA structure, B-DNA
01

Overview

The minor groove of double-stranded DNA, specifically at sequences rich in adenine (A) and thymine (T), is a critical structural target for a variety of small-molecule ligands and proteins (nih.gov, 2000; oup.com, 1993). AT-rich regions are characterized by a narrow, deep groove and a well-defined spine of hydration, which provides a unique shape and electrostatic environment that favors the binding of crescent-shaped molecules through van der Waals forces and hydrogen bonding (nih.gov, 2012; atdbio.com). Biologically, these regions are essential for the binding of architectural proteins and transcription factors, such as the TATA-binding protein (TBP), which are necessary for the initiation of transcription and DNA replication (nih.gov, 2000; researchgate.net, 2025). Drugs targeting the AT-rich minor groove, known as minor groove binders (MGBs), can displace the spine of hydration and disrupt these vital protein-DNA interactions, leading to the inhibition of gene expression and cell cycle progression (researchgate.net, 2013; nih.gov, 2000). Clinically, MGBs like pentamidine and diminazene are used as antiparasitic agents, often targeting the AT-rich kinetoplast DNA in pathogens, while others like CC-1065 derivatives have been explored for cancer therapy (nih.gov, 2012; researchgate.net, 2012). However, the development of these agents is often limited by non-specific toxicity and potential genotoxicity due to their interaction with the host genome (nih.gov, 2012; nih.gov, 2000).

Other names
AT-rich DNA minor grooveMinor groove of B-DNAAT-tractsMinor groove of AT-rich DNA
02

Mechanism of action

Non-covalent binding to the minor groove of AT-rich DNA; displacement of the spine of hydration; competitive inhibition of DNA-binding proteins such as transcription factors; interference with DNA replication and transcription; induction of DNA damage and apoptosis.

03

Biological functions

Genetic information storageTranscription regulationDNA replicationChromatin organization
04

Disease associations

CancerInfectionParasitic disease
05

Safety considerations

GenotoxicityMutagenicityHepatotoxicityNephrotoxicityOff-target effects on mitochondrial DNANarrow therapeutic index
06

Interacting drugs

Netropsin

9 more in the full profile.

07

Biomarkers

AT-rich DNA contentTATA-binding protein (TBP) expression levelsgamma-H2AX (DNA damage marker)Kinetoplast DNA presence

Beyond the preview

Go deeper on Double-stranded DNA minor groove at AT-rich sequences (DNA minor groove (AT-rich)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double-stranded DNA minor groove at AT-rich sequences (DNA minor groove (AT-rich)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call